Lucid Health Consulting Experience Matters. We provide expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market. Our expertise is in health economics, health technology assessments, pricing and reimbursement strategy. We provide our clients with comprehensive HTA packages and submissions along with in depth commercial and reimbursement feasibility assessments. Specialising in: – regulatory strategy and submissions – health technology assessment for reimbursement/submission preparation – pricing strategy, including negotiations and price defence – market access including advisory boards, commercial assessments and stakeholder mapping Lucid Health Consulting was founded in 2015 by three directors, George Papadopoulos, Michael Aristides and Steve Crowley. Each has over 25 years experience across the areas of health economics and market access. The directors are supported by an extended team with a proven track record in medical writing, biostatistics, economic modelling and medical information. The strength of Lucid Health Consulting is demonstrated by the quote from Aristotle, “the whole is greater than the sum of its parts”. By joining forces, the directors of Lucid Health Consulting each contribute their expertise to a project, resulting in a more comprehensive and ultimately more successful outcome. Our directors maintain a ‘hands-on’ approach, leading every project and acting as the key point of contact to provide seamless project management. We truly believe that “Experience Matters”. Lucid Health Consulting has prepared submissions for a range of advisory committees including PBAC, MSAC, PHARMAC, SMC, NICE and support packages in other European countries and Asia Pacific. Our offices are located in Sydney, Melbourne, Perth and San Diego.
